4//SEC Filing
Schultz Kare 4
Accession 0001209191-22-055177
CIK 0000818686other
Filed
Nov 1, 8:00 PM ET
Accepted
Nov 2, 8:55 AM ET
Size
7.5 KB
Accession
0001209191-22-055177
Insider Transaction Report
Form 4
Schultz Kare
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Ordinary Shares
2022-11-01+116,389→ 1,542,471 total - Exercise/Conversion
Restricted Share Units
2022-11-01−116,389→ 0 total→ Ordinary Shares (116,389 underlying)
Footnotes (3)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F3]Restricted share units were granted on November 3, 2017 with 63,613 vested on November 3, 2019, 180,000 vested on each of November 1, 2020 and November 1, 2021 and 116,389 vested on November 1, 2022.
Documents
Issuer
TEVA PHARMACEUTICAL INDUSTRIES LTD
CIK 0000818686
Entity typeother
Related Parties
1- filerCIK 0001724567
Filing Metadata
- Form type
- 4
- Filed
- Nov 1, 8:00 PM ET
- Accepted
- Nov 2, 8:55 AM ET
- Size
- 7.5 KB